An option for our patients suffering from severe opiate use disorder (dependency) is our MAT program. Pain medications, like codeine, oxycodone, and hydrocodone, can be highly addictive. These pain medications and other drugs like morphine and heroin are classified as opiates. If you or someone you know is struggling with opiate dependency, we can help. Nystrom & Associates, Ltd. (NAL), medication assisted treatment provides therapeutic interventions, including medication to reduce physical and psychological cravings for opiates in order for our patients to benefit fully from treatment.
Suboxone® (buprenorphine) is an FDA approved opioid partial agonist. An agonist is a chemical that binds to a receptor of a cell and triggers a response by that cell. Agonists often mimic the action of a naturally occurring substance. At low doses, buprenorphine produces sufficient agonist effects to enable opiate-addicted individuals to discontinue the use of opiates without experiencing withdrawal symptoms. The medication assisted treatment will be provided in an intensive outpatient treatment setting.
NAL’s Co-Occurring Chemical Dependency treatment programs offers day and evening programming that blends MAT patients into our treatment programs. In addition to our core programming, a MAT agreement detailing Suboxone® use expectations, drug testing, random drug recall, and medication safety procedures are followed. NAL utilizes a tapering protocol based on a patients need while they complete our outpatient treatment programming.
Patients will be approved for MAT based on recommendations from their Chemical Dependency evaluation and approval from our MAT prescribing physician.
Other team members will include Licensed Alcohol and Drug Counselor, Registered Dietitian, Licensed Psychologist and a Mental Health Professional.
MAT Program offers:
- Our Adult Co-Occurring Chemical Dependency treatment programming
- Mental health assessment
- Assessment and screening for medication readiness
- Nutritional assessment
- Base-line and random drug screening
- Psychological testing as needed
- Regular medication management (at Duluth or New Brighton locations)
- And other services as needed
Fees: As a licensed Rule 29 and 31 clinic, most commercial insurance plans, Medical Assistance, Prepaid Medical Assistance Plans (PMAPS) and CCDTF (Rule 25 Funding) are accepted. Patients using CCDTF (Rule 25 Funding) must also have Medical Assistance.
While patients prescribed Suboxone may attend treatment programming at any of our NAL locations, the patients MAT physician appointments are scheduled through our New Brighton, St. Cloud or Duluth locations only at this time.
For more information on our programs and scheduling, please contact our coordinators at: